1. Home
  2. OMH vs BCDA Comparison

OMH vs BCDA Comparison

Compare OMH & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMH
  • BCDA
  • Stock Information
  • Founded
  • OMH 2015
  • BCDA N/A
  • Country
  • OMH Singapore
  • BCDA United States
  • Employees
  • OMH N/A
  • BCDA N/A
  • Industry
  • OMH Real Estate
  • BCDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMH Finance
  • BCDA Health Care
  • Exchange
  • OMH Nasdaq
  • BCDA Nasdaq
  • Market Cap
  • OMH 8.0M
  • BCDA 7.9M
  • IPO Year
  • OMH 2023
  • BCDA N/A
  • Fundamental
  • Price
  • OMH $0.38
  • BCDA $2.84
  • Analyst Decision
  • OMH Strong Buy
  • BCDA Strong Buy
  • Analyst Count
  • OMH 1
  • BCDA 1
  • Target Price
  • OMH $1.50
  • BCDA $25.00
  • AVG Volume (30 Days)
  • OMH 141.6K
  • BCDA 58.1K
  • Earning Date
  • OMH 09-25-2024
  • BCDA 03-26-2025
  • Dividend Yield
  • OMH N/A
  • BCDA N/A
  • EPS Growth
  • OMH N/A
  • BCDA N/A
  • EPS
  • OMH N/A
  • BCDA N/A
  • Revenue
  • OMH $5,390,607.00
  • BCDA $71,000.00
  • Revenue This Year
  • OMH $101.90
  • BCDA N/A
  • Revenue Next Year
  • OMH $38.34
  • BCDA N/A
  • P/E Ratio
  • OMH N/A
  • BCDA N/A
  • Revenue Growth
  • OMH 25.77
  • BCDA N/A
  • 52 Week Low
  • OMH $0.32
  • BCDA $1.63
  • 52 Week High
  • OMH $1.19
  • BCDA $8.85
  • Technical
  • Relative Strength Index (RSI)
  • OMH 54.38
  • BCDA 67.71
  • Support Level
  • OMH $0.33
  • BCDA $2.27
  • Resistance Level
  • OMH $0.37
  • BCDA $2.78
  • Average True Range (ATR)
  • OMH 0.03
  • BCDA 0.26
  • MACD
  • OMH 0.00
  • BCDA 0.04
  • Stochastic Oscillator
  • OMH 46.97
  • BCDA 86.90

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: